Patient Information:

• Name: Guido Rico Agreda
• Diagnosis: Metastatic Adenocarcinoma of Colon
• Date of Birth (D.O.B): August 31, 1942
• Gender: Male
• Country: Bolivia

Treatment: Comprehensive Treatment at Beijing Puhua International Hospital for Metastatic Adenocarcinoma of Colon, including:

• Radio-Frequency Ablation (RFA)
• Systemic Chemotherapy (Capecitabine)
• Cytokine-Induced Killer Cells (CIK Cell) Therapy
• Traditional Chinese Medicine (TCM)

Medical History before Admission:

73-year-old male patient, Mr. Guido Rico Agreda:

• Underwent right semi-colectomy in 2006 for moderately-differentiated adenocarcinoma of the colon with positive lymph node involvement (+1/20), Dukes C.
• Completed adjuvant chemotherapy (12 cycles of 5-FU and LV civ48hs)
• Experienced progressive enlargement of peritoneal lymph nodes, necessitating excision in 20XX
• Undergone Radio-Frequency Ablation (RFA) for liver metastases

Treatment Details at Beijing Puhua International Hospital:

Radio-Frequency Ablation (RFA):

• Two procedures performed on September 15 and 29, 20XX respectively.
• Each procedure involved ablating two liver lesions using multi-electrode needles heated to 90°C for varying durations (10-15 minutes).
• Local injections of interleukin-2 (1,000,000 IU) and GM-CSF (150 µg) were administered post-procedure.
• Patient tolerated procedures well with no complications.

Systemic Chemotherapy:

• Capecitabine 825-1000mg/m² Bid, D1-14

Immunotherapy & Traditional Chinese Medicine (TCM):

• Cytokine-Induced Killer Cells (CIK cells) therapy administered twice during admission
• Acupuncture and Chinese herbal therapy to enhance energy, decrease toxicity, and improve general status

Medical Condition after Treatment:

Upon discharge, Mr. Agreda's physical condition showed continued improvement with no discomfort experienced throughout his treatment. Post-RFA treatments resulted in approximately 80% tumor load necrosis, which would gradually absorb over time. Optimal response evaluation via repeat CT or PET-CT scan recommended around one month post-treatment.

Post-Operative:

Mr. and Mrs. Agreda expressed high satisfaction with the cancer treatment and services provided at Beijing Puhua International Hospital. Mr. Agreda willingly shared his treatment experiences to benefit prospective patients.